Potential of anti-amyloid therapies for patients with Alzheimer disease in Canada
As the Canadian population ages, the prevalence of dementia due to Alzheimer disease is increasing,[1][1] placing substantial stress on affected individuals, their loved ones, and society as a whole. Development of novel pharmacologic therapies for Alzheimer disease has been challenging, with no new
Authors
- Frank Molnar (ORCID: https://orcid.org/0000-0001-5798-0159)
- Andrew Frank (ORCID: https://orcid.org/0009-0002-8587-7727)
- Chris Frank
Institutions
- Queen's University (CA)
- Ottawa Hospital (CA)
- Élisabeth Bruyère Hospital (CA)
Publication Details
- Journal
- Canadian Family Physician
- Published
- 2024-09-01
- DOI
- https://doi.org/10.46747/cfp.7009537
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00